Truncation of WT1 results in downregulation of cyclin G1 and IGFBP-4 expression

Biochemical and Biophysical Research Communications

Volumn 287, Issue 4, 2001, Pages 977-982

  Wagner, Kate J ^a   Patek, Charles E ^a   Miles, Colin ^b   Christie, Sheila ^b   Brookes, Anthony J ^b   Hooper, Martin L ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

cDNA macroarray; Cyclin G1; Denys Drash syndrome; ES cells; Gene targeting; IGFBP 4; Kidney; Target genes; Wilms' tumour; WT1

Indexed keywords

COMPLEMENTARY DNA; CYCLIN G1; CYCLINE; GENE PRODUCT; SOMATOMEDIN BINDING PROTEIN 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENYS DRASH SYNDROME; DNA BINDING; EMBRYO; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; MOUSE; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035812757     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5693     Document Type: Article

References (23)

1. Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridisation
2. Donor splice site mutations in WT1 are responsible for Frasier syndrome
3. Role of insulin-like growth factor binding proteins in the control of IGF actions
4. Insulin-like growth factor binding protein-4, protein-5, and protein-6 messenger RNA in the human fetus: Localisation to sites of growth and differentiation
5. The concentration of retinoic acid determines the differentiated cell types formed by a teratoma cell line
6. Truncated WT1 mutants alter the subnuclear localization of the wild-type protein
7. Characterization of insulin-like growth factor binding proteins and regulation of IGFBP3 in human mesangial cells
8. Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell-cycle regulated expression
9. Subnuclear localisation of WT1 in splicing or transcription factor domains is regulated by alternative splicing
10. The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin
11. Wilms' tumor and the WT1 gene
12. Gene expression of the insulin-like growth factor system during mouse kidney development
13. DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations
14. WT1: What has the last decade told us?
15. Loss of WT1 function leads to ectopic myogenesis in Wilms' tumour
16. A role of cyclin G in the process of apoptosis
17. A zinc finger truncation of murine WT1 results in the characteristic nephropathy of Denys-Drash syndrome
18. Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21
19. The WT1 Wilms' tumor suppressor gene: How much do we really know?
20. Heat shock factors and the control of the stress response
21. Differential regulation of the Wilms' tumor gene, Wt1, during differentiation of embryonal carcinoma and embryonic stem cells
22. Identification of connective tissue growth factor as a target of WT1 transcriptional regulation
23. Growth inhibition of human leukaemic cells by WT1 (Wilms' tumor gene) antisense oligonucleotides: Implications for the involvement of WT1 in leukemogenesis